Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Agave Inulin for BPH and Metabolic Syndrome
NCT02778776Phase 3Completed
- Sponsor
- Centro Universitario de Ciencias de la Salud
- Start
- Jan 2013
- Primary completion
- Jun 2015
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs), agave inulin in benign prostatic hyperplasia (BPH), metabolic syndrome, sponsored by Centro Universitario de Ciencias de la Salud. Started Jan 2013; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)agave inulin
03
Conditions
benign prostatic hyperplasia (BPH)metabolic syndrome
Beyond the preview
Go deeper on NCT02778776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02778776.